The justices considered a challenge to the Food and Drug Administration’s regulation ... of the challenge to the mifepristone ...
The U.K. government has approved new rules for hemp cultivation designed to ease growing the crop for farmers and spur new ...
Because this platinum drug shortage crisis won't be the last, oncology practices need to be better prepared to tackle future ...
Recreational marijuana remains illegal in about half of the U.S. as products that deliver a similar high gain popularity in ...
Earlier this year, the US Food and Drug Administration (FDA) published new draft guidance substantially revising the agency’s previous guidance on the Establishment and Operation of Clinical Trial ...
The abortion opponents who challenged the FDA's approval of mifepristone and subsequent actions to ease access to it ... "In loosening mifepristone's safety restrictions, FDA failed to address ...
Abortion opponents are making a fervent plea to the U.S. Supreme Court, aiming to curtail access to the abortion pill, mifepristone. President Joe Biden's administration is contesting a lower ...
At issue in the case are lower-court rulings that would have rolled back recent Food and Drug Administration decisions to ease access to ... from the agency’s regulations.
Pricing: Weight loss medications can cost as low as $199 per monthly (compound Semaglutide), or as much as $1,000 per month ...
"If this medication is restricted or banned completely, no one will be able to get access to it with any ease," she says ... regardless of state restrictions.) 6. The drug industry could face ...
The justices considered a challenge to the Food and Drug Administration ... mifepristone regulations brought by a group of anti-abortion doctors -- suggesting recent steps to ease access to ...